Analysts expect Cellectar Biosciences, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 770,534.02 | 1.17 M | 10.41 M | 12.44 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 661,419.18 | 1.05 M | 8.88 M | 11.71 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 715,976.60 | 1.11 M | 9.65 M | 12.08 M |
Analysts expect Cellectar Biosciences, Inc. to report earnings per share of -0.53 for Q3 26, against a range of -0.57 to -0.49. The most recent reported quarter, Q2 26, came in at -0.57, a 3.6% miss against the -0.55 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -12.00 | -2.10 | -4.20 | -3.39 | -1.41 | 0.65 | -1.33 | -0.57 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -9.59 | -10.43 | -4.84 | -3.57 | -2.22 | -1.24 | -1.72 | -0.50 | -0.49 | -0.49 | -0.44 | -0.61 | 1.19 | 2.02 | -1.42 | -1.37 | ||||||||||
| Low Estimate | -11.19 | -11.83 | -5.16 | -4.17 | -2.50 | -1.34 | -1.92 | -0.60 | -0.57 | -0.55 | -0.52 | -0.67 | 1.01 | 1.74 | -1.66 | -1.59 | ||||||||||
| Consensus Estimate | -10.39 | -11.13 | -5.00 | -3.87 | -2.36 | -1.29 | -1.82 | -0.55 | -0.53 | -0.52 | -0.48 | -0.64 | 1.10 | 1.88 | -1.54 | -1.48 |
Pull Wall Street consensus for Cellectar Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CLRB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CLRB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CLRB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();